Logo image of ALIMP.PA

IMPLANET (ALIMP.PA) Stock Fundamental Analysis

EPA:ALIMP - Euronext Paris - Matif - FR0013470168 - Common Stock - Currency: EUR

0.099  0 (0%)

Fundamental Rating

1

Overall ALIMP gets a fundamental rating of 1 out of 10. We evaluated ALIMP against 59 industry peers in the Health Care Equipment & Supplies industry. ALIMP has a bad profitability rating. Also its financial health evaluation is rather negative. ALIMP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALIMP has reported negative net income.
In the past year ALIMP has reported a negative cash flow from operations.
ALIMP had negative earnings in each of the past 5 years.
ALIMP had a negative operating cash flow in each of the past 5 years.
ALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFALIMP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

With a Return On Assets value of -29.32%, ALIMP is not doing good in the industry: 77.97% of the companies in the same industry are doing better.
With a Return On Equity value of -600.55%, ALIMP is not doing good in the industry: 86.44% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -29.32%
ROE -600.55%
ROIC N/A
ROA(3y)-38.85%
ROA(5y)-36.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALIMP.PA Yearly ROA, ROE, ROICALIMP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

The Gross Margin of ALIMP (53.05%) is comparable to the rest of the industry.
ALIMP's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ALIMP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.33%
GM growth 5Y-1.07%
ALIMP.PA Yearly Profit, Operating, Gross MarginsALIMP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

0

2. Health

2.1 Basic Checks

ALIMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALIMP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALIMP has been increased compared to 5 years ago.
Compared to 1 year ago, ALIMP has an improved debt to assets ratio.
ALIMP.PA Yearly Shares OutstandingALIMP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALIMP.PA Yearly Total Debt VS Total AssetsALIMP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -0.81, we must say that ALIMP is in the distress zone and has some risk of bankruptcy.
ALIMP has a Altman-Z score of -0.81. This is in the lower half of the industry: ALIMP underperforms 77.97% of its industry peers.
A Debt/Equity ratio of 3.69 is on the high side and indicates that ALIMP has dependencies on debt financing.
ALIMP's Debt to Equity ratio of 3.69 is on the low side compared to the rest of the industry. ALIMP is outperformed by 84.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.69
Debt/FCF N/A
Altman-Z -0.81
ROIC/WACCN/A
WACC6.09%
ALIMP.PA Yearly LT Debt VS Equity VS FCFALIMP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.85 indicates that ALIMP may have some problems paying its short term obligations.
ALIMP's Current ratio of 0.85 is on the low side compared to the rest of the industry. ALIMP is outperformed by 84.75% of its industry peers.
ALIMP has a Quick Ratio of 0.85. This is a bad value and indicates that ALIMP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.38, ALIMP is not doing good in the industry: 86.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.38
ALIMP.PA Yearly Current Assets VS Current LiabilitesALIMP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2

3. Growth

3.1 Past

ALIMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.71%, which is quite impressive.
Looking at the last year, ALIMP shows a very strong growth in Revenue. The Revenue has grown by 26.31%.
Measured over the past years, ALIMP shows a small growth in Revenue. The Revenue has been growing by 4.89% on average per year.
EPS 1Y (TTM)73.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.87%
Revenue 1Y (TTM)26.31%
Revenue growth 3Y15.28%
Revenue growth 5Y4.89%
Sales Q2Q%66.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALIMP.PA Yearly Revenue VS EstimatesALIMP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALIMP.PA Yearly EPS VS EstimatesALIMP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 -10 -20 -30 -40

0

4. Valuation

4.1 Price/Earnings Ratio

ALIMP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALIMP.PA Price Earnings VS Forward Price EarningsALIMP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALIMP.PA Per share dataALIMP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALIMP!.
Industry RankSector Rank
Dividend Yield N/A

IMPLANET

EPA:ALIMP (6/18/2025, 7:00:00 PM)

0.099

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.37M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.32
P/FCF N/A
P/OCF N/A
P/B 17.02
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.08
BVpS0.01
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.32%
ROE -600.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.05%
FCFM N/A
ROA(3y)-38.85%
ROA(5y)-36.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.33%
GM growth 5Y-1.07%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 3.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.33%
Cap/Sales 5.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.38
Altman-Z -0.81
F-Score4
WACC6.09%
ROIC/WACCN/A
Cap/Depr(3y)21.16%
Cap/Depr(5y)17.19%
Cap/Sales(3y)3.98%
Cap/Sales(5y)3.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.31%
Revenue growth 3Y15.28%
Revenue growth 5Y4.89%
Sales Q2Q%66.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.49%
OCF growth 3YN/A
OCF growth 5YN/A